Literature DB >> 24075781

Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-κB-independent and ERK-dependent pathway.

Yuxin Xie1, Yan Li, Xingchen Peng, Xinchen Peng, Fraser Henderson, Ling Deng, Nianyong Chen.   

Abstract

OBJECTIVES: Ikappa B kinase alpha (IKKα) plays an inhibitory role in the development of epithelial-derived tumors. However, its specific function in the development of nasopharyngeal carcinoma (NPC) remains unknown. In this study we identify the role and mechanism of IKKα in IKKα-mediated NPC development.
MATERIAL AND METHODS: The effect of IKKα on migration, invasion and tumorigenesis of NPC cell lines was determined using in vitro and in vivo studies. SUNE-1-5-8F cells transfected to overexpress IKKα, SUNE-1-6-10B cells with shRNA-mediated knockdown of IKKα, and three NPC cell lines were studied using Western blotting techniques to compare the major molecules in NF-κB pathways. Additionally, the extracellular signal-regulated kinase (ERK) pathway and matrix metalloproteinases (MMPs) in IKKα-regulated NPC and the effect of Epstein-Barr Nuclear Antigen 1 (EBNA1) on IKKα were examined.
RESULTS: IKKα was underexpressed in highly invasive SUNE-1-5-8F cells compared with non-invasive cells (SUNE-1 and SUNE-6-10B). Overexpression of IKKα in SUNE-1-5-8F cells was achieved through transfection and resulted in inhibited migration and invasion in vitro. Furthermore, IKKα inhibited tumorigenesis in mice inoculated with IKKα-transfected NPC cells in vivo. These processes were independent of the conventional effect of IKKα on Nuclear factor κB (NF-κB) pathways. The ERK pathway was involved in IKKα-related NPC inhibition. Phosphorylation of ERK1/2 and subsequent secretion of MMP-9 were inhibited by the ERK inhibitor U0126 and not regulated by overexpressed IKKα. EBNA1 knockdown using small interfering RNA (siRNA) did not alter the expression of IKKα.
CONCLUSION: Increase in IKKα expression suppresses the progression of NPC through a NF-κB-independent and ERK-dependent pathway.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alternative NF-κB; ERK; Ikappa B kinase alpha; NF-κB; Nasopharyngeal carcinoma; Non-canonical NF-κB; Tumor suppressor

Mesh:

Substances:

Year:  2013        PMID: 24075781     DOI: 10.1016/j.oraloncology.2013.08.008

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  Opposed expression of IKKα: loss in keratinizing carcinomas and gain in non-keratinizing carcinomas.

Authors:  Desheng Xiao; Jiantao Jia; Ying Shi; Chunyan Fu; Ling Chen; Yiqun Jiang; Li Zhou; Shuang Liu; Yongguang Tao
Journal:  Oncotarget       Date:  2015-09-22

2.  Indole-3-carbinol inhibits nasopharyngeal carcinoma growth through cell cycle arrest in vivo and in vitro.

Authors:  Zhe Chen; Ze-Zhang Tao; Shi-Ming Chen; Chen Chen; Fen Li; Bo-kui Xiao
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.752

3.  Periplaneta americana Extracts Promote Skin Wound Healing via Nuclear Factor Kappa B Canonical Pathway and Extracellular Signal-Regulated Kinase Signaling.

Authors:  Qin Song; Qiheng Gou; Yuxin Xie; Zhen Zhang; Chaomei Fu
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-23       Impact factor: 2.629

4.  The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling.

Authors:  Wen-Ze Qiu; Hai-Bo Zhang; Wei-Xiong Xia; Liang-Ru Ke; Jing Yang; Ya-Hui Yu; Hu Liang; Xin-Jun Huang; Guo-Ying Liu; Wang-Zhong Li; Yan-Qun Xiang; Tie-Bang Kang; Xiang Guo; Xing Lv
Journal:  J Exp Clin Cancer Res       Date:  2018-04-17

5.  Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression.

Authors:  Pei-Chan Zheng; Xiong Chen; Hong-Wu Zhu; Wei Zheng; Li-Hua Mao; Cheng Lin; Jing-Nan Liu; Ming Zheng
Journal:  Cancer Sci       Date:  2014-05-21       Impact factor: 6.716

6.  ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.

Authors:  Yuxin Xie; Qiheng Gou; Keqi Xie; Zhu Wang; Yanping Wang; Hong Zheng
Journal:  Oncotarget       Date:  2016-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.